Ten identified publications reported effects of setmelanotide on weight, hunger, or health-related QOL (HRQOL) in patients with rare MC4R pathway diseases associated with hyperphagia and obesity [12–14, 28, 71, 122–126]. Here, MC4R is linked to obesity disorder.